Introduction

This page provides a comprehensive analysis of the known insider trading history of Daniel R Marshak. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Daniel R Marshak has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:NVIV / InVivo Therapeutics Holdings Corp. Director 15,000
US:PKI / Revvity Inc. SVP & CSO 67,743
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Daniel R Marshak. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by Daniel R Marshak as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2021-03-22 2021-03-18 4 NVIV INVIVO THERAPEUTICS HOLDINGS CORP.
Stock option (right to buy)
A - Award 15,000 15,000
2018-01-23 2018-01-19 4 NVIV INVIVO THERAPEUTICS HOLDINGS CORP.
Stock Option (Right to Buy)
A - Award 12,500 12,500
2017-01-23 2017-01-18 4 NVIV INVIVO THERAPEUTICS HOLDINGS CORP.
Stock Option (Right to Buy)
A - Award 12,500 12,500
2015-12-11 2015-12-10 4 NVIV INVIVO THERAPEUTICS HOLDINGS CORP.
Stock Option (Right to Buy)
A - Award 12,500 12,500
2014-12-11 2014-12-10 4 NVIV INVIVO THERAPEUTICS HOLDINGS CORP.
Stock Option (Right to Buy)
A - Award 50,000 50,000
2014-09-30 2014-09-29 4 NVIV INVIVO THERAPEUTICS HOLDINGS CORP.
Stock Option (Right to Buy)
A - Award 50,000 50,000
2014-09-29 2014-09-26 4 PKI PERKINELMER INC
Common Stock
D - Sale to Issuer -5,194 67,743 -7.12
2014-09-29 2014-09-26 4 PKI PERKINELMER INC
Common Stock
D - Sale to Issuer -6,356 72,937 -8.02
2014-09-29 2014-09-26 4 PKI PERKINELMER INC
Common Stock
D - Sale to Issuer -8,117 79,293 -9.29
2014-08-07 2014-08-06 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
M - Exercise -31,413 0 -100.00
2014-08-07 2014-08-06 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
M - Exercise -10,552 0 -100.00
2014-08-07 2014-08-06 4 PKI PERKINELMER INC
Common Stock
M - Exercise 31,413 87,410 56.10 21.00 659,830 1,836,047
2014-08-07 2014-08-06 4 PKI PERKINELMER INC
Common Stock
M - Exercise 10,552 55,997 23.22 12.94 136,596 724,881
2014-07-09 2014-07-07 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
M - Exercise -100 31,413 -0.32
2014-07-09 2014-07-07 4 PKI PERKINELMER INC
Common Stock
S - Sale X -100 45,445 -0.22 48.02 -4,802 2,182,496
2014-07-09 2014-07-07 4 PKI PERKINELMER INC
Common Stock
M - Exercise 100 45,545 0.22 21.00 2,100 956,673
2014-07-07 2014-07-02 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
M - Exercise -12,000 10,552 -53.21
2014-07-07 2014-07-02 4 PKI PERKINELMER INC
Common Stock
S - Sale X -12,000 45,445 -20.89 48.00 -576,000 2,181,360
2014-07-07 2014-07-02 4 PKI PERKINELMER INC
Common Stock
M - Exercise 12,000 57,445 26.41 12.94 155,340 743,626
2014-06-27 2014-06-26 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
M - Exercise -10,000 22,552 -30.72
2014-06-27 2014-06-26 4 PKI PERKINELMER INC
Common Stock
S - Sale X -10,000 45,445 -18.04 46.60 -465,970 2,117,601
2014-06-27 2014-06-26 4 PKI PERKINELMER INC
Common Stock
M - Exercise 10,000 55,445 22.00 12.94 129,450 717,736
2014-03-13 2014-03-12 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
M - Exercise -19,292 0 -100.00
2014-03-13 2014-03-12 4 PKI PERKINELMER INC
Common Stock
S - Sale X -19,292 45,445 -29.80 45.29 -873,754 2,058,249
2014-03-13 2014-03-12 4 PKI PERKINELMER INC
Common Stock
M - Exercise 19,292 64,737 42.45 25.02 482,686 1,619,720
2014-02-11 2014-02-10 4 PKI PERKINELMER INC
Common Stock
F - Taxes -2,511 45,445 -5.24 43.78 -109,932 1,989,582
2014-02-06 2014-02-04 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
A - Award 18,808 18,808
2014-02-06 2014-02-04 4 PKI PERKINELMER INC
Common Stock
A - Award 5,194 47,956 12.15
2013-12-11 2013-12-10 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
M - Exercise -12,183 0 -100.00
2013-12-11 2013-12-10 4 PKI PERKINELMER INC
Common Stock
S - Sale X -12,183 42,762 -22.17 39.59 -482,325 1,692,948
2013-12-11 2013-12-10 4 PKI PERKINELMER INC
Common Stock
M - Exercise 12,183 54,945 28.49 23.45 285,691 1,288,460
2013-03-11 2013-03-08 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
M - Exercise -15,000 0 -100.00
2013-03-11 2013-03-08 4 PKI PERKINELMER INC
Common Stock
S - Sale X -15,000 42,762 -25.97 35.26 -528,825 1,507,574
2013-03-11 2013-03-08 4 PKI PERKINELMER INC
Common Stock
M - Exercise 15,000 57,762 35.08 20.50 307,425 1,183,832
2013-02-12 2013-02-11 4 PKI PERKINELMER INC
Common Stock
F - Taxes -2,927 42,762 -6.41 34.75 -101,713 1,485,980
2013-02-12 2013-02-08 4 PKI PERKINELMER INC
Common Stock
F - Taxes -261 45,689 -0.57 34.49 -9,002 1,575,814
2013-02-07 2013-02-05 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
A - Award 19,862 19,862
2013-02-07 2013-02-05 4 PKI PERKINELMER INC
Common Stock
A - Award 6,356 45,950 16.05
2012-02-09 2012-02-08 4 PKI PERKINELMER INC
Common Stock
F - Taxes -256 39,594 -0.64 26.18 -6,702 1,036,571
2012-02-09 2012-02-07 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
A - Award 29,030 29,030
2012-02-09 2012-02-07 4 PKI PERKINELMER INC
Common Stock
A - Award 8,117 39,850 25.58
2012-01-31 2012-01-27 4 PKI PERKINELMER INC
Common Stock
F - Taxes -1,148 31,733 -3.49 24.12 -27,690 765,400
2009-02-03 2009-02-03 4 PKI PERKINELMER INC
NQ Stock Option (right to buy)
A - Award 32,552 32,552
2009-02-03 2009-02-03 4 PKI PERKINELMER INC
Common Stock
A - Award 9,586 24,044 66.30
2008-04-23 3 PKI PERKINELMER INC
Common Stock
14,418
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)